The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.



Heng Xin China Holdings Limited

恒 芯 中 國 控 股 有 限 公 司*

(Incorporated in Bermuda with limited liability)

(Stock code: 8046)


FURTHER EXTENSION OF THE LONG STOP DATE FOR COMPLETION OF CAPITAL INJECTION IN SHANXI ZHONGZE HENG YUAN BIOLOGICAL TECHNOLOGY COMPANY LIMITED*


Reference is made to (i) the announcement of the Company dated 26 January 2015 in relation to the Capital Injection of RMB52 million by Beijing Kaiqiao to the Target Company pursuant to the Capital Injection Agreement dated 26 January 2015 entered into between Beijing Kaiqiao, Zhong Xiang and Hu Guosheng (the 'Announcement'); (ii) the announcement of the Company dated 29 May 2015 in relation to the extension of the long stop date ('Long Stop Date') for the completion of the Capital Injection to 31 July 2015;

(iii) the announcement of the Company dated 31 July 2015 in relation to the further extension of the Long Stop Date to 30 September 2015; (iv) the announcement of the Company dated 30 September 2015 in relation to, among other matters, further extension of the Long Stop Date to 31 October 2015; and (v) the announcement of the Company dated 29 October 2015 in relation to the further extension of the Long Stop Date to 30 November 2015.


Capitalised terms used in this announcement shall have the same meanings as those defined in the Announcement unless the context otherwise requires.

On 30 November 2015, Beijing Kaiqiao, Zhong Xiang and Hu Guosheng have agreed in writing to further extend the Long Stop Date to 31 December 2015 as additional time is required for fulfilment of the conditions precedent set out in the Capital Injection Agreement. The Board considers that such extension of the Long Stop Date is in the interest of the Company and the Shareholders as a whole. Save and except for the aforesaid extension of the Long Stop Date, all other terms and conditions of the Capital Injection Agreement shall remain unchanged and continue in full force and effect.


By Order of the Board

HENG XIN CHINA HOLDINGS LIMITED Xiao Yan

Chief Executive Officer


Hong Kong, 30 November 2015


As at the date of this announcement, the Board comprises Mr. Xiao Yan (Chief Executive Officer), Mr. Qiu Bin, Mr. Li Tao, Mr. Wang Kun and Mr. Li Nan as executive Directors; Mr. Xu Lei as non-executive Director; and Mr. Leung Wo Ping JP, Mr. Dong Shi, Mr. Hu Dingdong, Mr. Lei Yong and Mr. Gao Yang as independent non-executive Directors.


This announcement, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the GEM Listing Rules for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this announcement misleading.


This announcement will remain on the GEM website at www.hkgem.com on the 'Latest Company Announcement' page for at least 7 days from the date of its posting and on the website of the Company at www.hengxinchina.com.hk.


* For identification purposes only

distributed by